Leukodystrophy, Metachromatic: Clinical Trials

1 trial for Leukodystrophy, Metachromatic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Leukodystrophy, Metachromatic: new trials by email Literature Review of Leukodystrophy, Metachromatic trials Research Report on Leukodystrophy, Metachromatic

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
hematopoietic stem cell infusion - Hurler Syndrome (MPS I), Hurler-Scheie Syndrome
Phase 1 / Phase 2TerminatedTalaris Therapeutics Inc.32011-04-012023-04-12

Narrower conditions

Adrenoleukodystrophy (1)  ·  Leukodystrophy, Globoid Cell (1)  ·  Mucopolysaccharidosis I (1)  ·  Mucopolysaccharidosis II (1)  ·  Mucopolysaccharidosis III (1)  ·  Niemann-Pick Diseases (1)  ·  Sandhoff Disease (1)  ·  Sudden Infant Death (1)  ·  Tay-Sachs Disease (1)  ·  alpha-Mannosidosis (1)

Broader conditions

Adrenal Gland Diseases (1)  ·  Adrenal Insufficiency (1)  ·  Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Central Nervous System Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Death (1)  ·  Death, Sudden (1)  ·  Demyelinating Diseases (1)  ·  Endocrine System Diseases (1)  ·  Gangliosidoses (1)  ·  Gangliosidoses, GM2 (1)

Interventions

Stem Cell Transplantation (1)

Sponsors

Talaris Therapeutics Inc. (1)

Countries

United States (1)

Top investigators

Suzanne T Ildstad, MD (1)